查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1473827

下一代避孕药具市场 - 全球和区域分析：全球和区域分析：按性别、产品、最终用户、地区 - 分析和预测（2024-2033）

Next-Generation Contraceptives Market - A Global and Regional Analysis: Focus on Gender, Offering, End User, and Region - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 | 商品交期: 7-10个工作天内

价格
简介目录

该报告研究了全球下一代避孕药市场，并提供了市场概述，包括按性别、产品、最终用户、地区和参与市场的公司概况分類的趋势。

目录

执行摘要

第一章市场：产业展望

  • 趋势：当前和未来的影响评估
  • 供应链概览
  • 研发回顾
  • 监管状况
  • 市场动态概览

第二章 下一代避孕药具市场（依用途）

  • 应用细分
  • 应用概述
  • 全球下一代避孕药具市场，性别
  • 全球下一代避孕药具市场（按最终用户）

第三章下一代避孕药市场，依产品类型

  • 产品细分
  • 产品概要
  • 全球下一代避孕药具市场（按产品划分）

第四章下一代避孕药具市场（按地区）

  • 区域概况
  • 促进因素和抑制因素
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第五章市场-竞争格局与公司概况

  • 竞争格局
  • 公司简介
    • AbbVie
    • Bayer Corporation
    • Cooper Surgical, Inc.
    • Church & Dwight Co, Inc.
    • Merck & Co Inc.
    • Pfizer
    • Reckitt Benckiser Group Plc
    • Teva Pharmaceuticals Industries Ltd.
    • The Female Health Company/Veru Inc.
    • Afaxys, Inc
    • Aditxt
    • Dare Bioscience, Inc
    • TherapeuticsMD, Inc
    • 其他公司

第六章调查方法

简介目录
Product Code: BHL2050SA

This report will be delivered in 7-10 working days.

The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.

The market study encompasses a detailed examination of various next-generation contraceptives including technological advancements, and market dynamics. It explores the market based on segmentations such as by gender, and by offering and by distribution channel and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.

With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global next-generation contraceptives market.

Market Segmentation

Segmentation 1: by Gender

  • Male
  • Female

Segmentation 2: by by End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels
  • Others

Segmentation 3: by Offering

  • Drugs
  • Devices

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • Latin America

Key Questions Answered:

  • What are the major market drivers, challenges, and opportunities in the global next-generation contraceptives market and their case studies?
  • How will the next-generation contraceptives market evolve and what is its scope in the future?
  • What is the market share of the leading segments and sub-segments of the global next-generation contraceptives market?
  • How will each segment of the global next-generation contraceptives market grow during the forecast period?
  • What are the key developmental strategies implemented by the key players to stand out in this market?

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1 Markets: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
  • 1.2 Supply Chain Overview
    • 1.2.1 Value chain Analysis
    • 1.2.2 Market Map
  • 1.3 R&D Review
    • 1.3.1 Patent Filing Trend by Country, by Company
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics Overview
    • 1.5.1 Market Drivers
    • 1.5.2 Market Restraints
    • 1.5.3 Market Opportunities

2 Next-Generation Contraceptives Market by Application

  • 2.1 Application Segmentation
  • 2.2 Application Summary
  • 2.3 Global Next-Generation Contraceptives Market, by Gender
    • 2.3.1 Male
    • 2.3.2 Female
  • 2.4 Global Next-Generation Contraceptives Market, by End User
    • 2.4.1 Hospital Pharmacies
    • 2.4.2 Retail Pharmacies
    • 2.4.3 Online Channels
    • 2.4.4 Others

3 Next-Generation Contraceptives Market by Product Type

  • 3.1 Product Segmentation
  • 3.2 Product Summary
  • 3.3 Global Next-Generation Contraceptives Market, by Offering
    • 3.3.1 Drugs
      • 3.3.1.1 Contraceptive Pills
      • 3.3.1.2 Injectables
      • 3.3.1.3 Patches
      • 3.3.1.4 Others
    • 3.3.2 Devices
      • 3.3.2.1 Condoms
      • 3.3.2.2 Vaginal Rings
      • 3.3.2.3 Intra-uterine Devices
      • 3.3.2.4 Others

4 Next-Generation Contraceptives Market by Region

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints as you go along...
  • 4.3 North America
    • 4.3.1 Markets
      • 4.3.1.1 Key Market Participants in North America
      • 4.3.1.2 Business Drivers
      • 4.3.1.3 Business Challenges
    • 4.3.2 North America Next Generation Contraceptives Market, by End User
    • 4.3.3 North America by Country
      • 4.3.3.1 U.S.
      • 4.3.3.2 Canada
  • 4.4 Europe
    • 4.4.1 Markets
      • 4.4.1.1 Key Market Participants in Europe
      • 4.4.1.2 Business Drivers
      • 4.4.1.3 Business Challenges
    • 4.4.2 Europe Next Generation Contraceptives Market, by End User
    • 4.4.3 Europe by Country
      • 4.4.3.1 U.K.
      • 4.4.3.2 Germany
      • 4.4.3.3 France
      • 4.4.3.4 Italy
      • 4.4.3.5 Spain
      • 4.4.3.6 Rest of Europe
  • 4.5 Asia-Pacific
    • 4.5.1 Markets
      • 4.5.1.1 Key Market Participants in Asia-Pacific
      • 4.5.1.2 Business Drivers
      • 4.5.1.3 Business Challenges
    • 4.5.2 Asia-Pacific America Next Generation Contraceptives Market, by End User
    • 4.5.3 Asia-Pacific by Country
      • 4.5.3.1 China
      • 4.5.3.2 Japan
      • 4.5.3.3 India
      • 4.5.3.4 South Korea
      • 4.5.3.5 Rest of Asia-Pacific
  • 4.6 Latin America
    • 4.6.1 Markets
      • 4.6.1.1 Key Market Participants in Latin America
      • 4.6.1.2 Business Drivers
      • 4.6.1.3 Business Challenges
    • 4.6.2 Latin America Next Generation Contraceptives Market, by End User
    • 4.6.3 Latin America by Country
      • 4.6.3.1 Brazil
      • 4.6.3.2 Mexico
      • 4.6.3.3 Rest of Latin America
  • 4.7 Middle East and Africa
    • 4.7.1 Markets
      • 4.7.1.1 Key Market Participants in Middle East and Africa
      • 4.7.1.2 Business Drivers
      • 4.7.1.3 Business Challenges
    • 4.7.2 Middle East and Africa Next Generation Contraceptives Market, by End User

5 Markets - Competitive Landscape & Company Profiles

  • 5.1 Competitive Landscape
  • 5.2 Company Profiles
    • 5.2.1 AbbVie
      • 5.2.1.1 Company Overview
      • 5.2.1.2 Top Products / Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers /End-Users
      • 5.2.1.5 Key Personnel
      • 5.2.1.6 Analyst View
    • 5.2.2 Bayer Corporation
      • 5.2.2.1 Company Overview
      • 5.2.2.2 Top Products / Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers /End-Users
      • 5.2.2.5 Key Personnel
      • 5.2.2.6 Analyst View
    • 5.2.3 Cooper Surgical, Inc.
      • 5.2.3.1 Company Overview
      • 5.2.3.2 Top Products / Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers /End-Users
      • 5.2.3.5 Key Personnel
      • 5.2.3.6 Analyst View
    • 5.2.4 Church & Dwight Co, Inc.
      • 5.2.4.1 Company Overview
      • 5.2.4.2 Top Products / Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers /End-Users
      • 5.2.4.5 Key Personnel
      • 5.2.4.6 Analyst View
    • 5.2.5 Merck & Co Inc.
      • 5.2.5.1 Company Overview
      • 5.2.5.2 Top Products / Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers /End-Users
      • 5.2.5.5 Key Personnel
      • 5.2.5.6 Analyst View
    • 5.2.6 Pfizer
      • 5.2.6.1 Company Overview
      • 5.2.6.2 Top Products / Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers /End-Users
      • 5.2.6.5 Key Personnel
      • 5.2.6.6 Analyst View
    • 5.2.7 Reckitt Benckiser Group Plc
      • 5.2.7.1 Company Overview
      • 5.2.7.2 Top Products / Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers /End-Users
      • 5.2.7.5 Key Personnel
      • 5.2.7.6 Analyst View
    • 5.2.8 Teva Pharmaceuticals Industries Ltd.
      • 5.2.8.1 Company Overview
      • 5.2.8.2 Top Products / Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers /End-Users
      • 5.2.8.5 Key Personnel
      • 5.2.8.6 Analyst View
    • 5.2.9 The Female Health Company/Veru Inc.
      • 5.2.9.1 Company Overview
      • 5.2.9.2 Top Products / Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers /End-Users
      • 5.2.9.5 Key Personnel
      • 5.2.9.6 Analyst View
    • 5.2.10 Afaxys, Inc
      • 5.2.10.1 Company Overview
      • 5.2.10.2 Top Products / Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers /End-Users
      • 5.2.10.5 Key Personnel
      • 5.2.10.6 Analyst View
    • 5.2.11 Aditxt
      • 5.2.11.1 Company Overview
      • 5.2.11.2 Top Products / Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Target Customers /End-Users
      • 5.2.11.5 Key Personnel
      • 5.2.11.6 Analyst View
    • 5.2.12 Dare Bioscience, Inc
      • 5.2.12.1 Company Overview
      • 5.2.12.2 Top Products / Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Target Customers /End-Users
      • 5.2.12.5 Key Personnel
      • 5.2.12.6 Analyst View
    • 5.2.13 TherapeuticsMD, Inc
      • 5.2.13.1 Company Overview
      • 5.2.13.2 Top Products / Product Portfolio
      • 5.2.13.3 Top Competitors
      • 5.2.13.4 Target Customers /End-Users
      • 5.2.13.5 Key Personnel
      • 5.2.13.6 Analyst View
    • 5.2.14 Other Companies

6 Research Methodology